Journal of Pharmaceutical and Biomedical Sciences

Vascular Thoracic Fibrous Adipose Tissue (New Disease)

Giorgio Maria Paul Graziano, Giovanni Castelli, Antonino Graziano

Abstract


Indroduction The primary tumors of the chest wall are rare, about 2% of all cancers, and 50% are derived from soft tissue neoplasms, benign or malignant that arise at the level of the chest wall representing 2% of all cancers; the study reports a recent observation of primitive thoracic neoplasia, and discusses the diagnosis and treatment of cancer.
Materials and Methods Paz 49 sex male has come to our attention in February 2016 at The Second Surgical Clinic of the University of Catania. The clinical history of the patient showed the presence in the dorsal thorax Ds, the formation presents a cranium caudal extension of about 190 mm, a lateral-lateral diameter of about 120 mm and an anteroposterior diameter of about 50 mm displaces posteriorly and the trapezius the latissimus dorsi and contracted close relations of contiguity with paraspinal muscles. It presents heterogeneous signal in T1 and T2.
Results The specifications with the different methods of imaging the face of a patient with expansive lesion that presented palpable mass in rapid growth (2), has been that of the identification of the lesion, with a spatial evaluation, typing, directing toward a diagnostic orientation of probable kindness.
Discussion The computed tomography (CT) allows in most cases the differential diagnosis of a neoplasm of the chest wall and defines its characteristics, the origin (in the case of the wall intrusive tumors by contiguity), the location, and the relationships with surrounding structures (Fig. 1). It also allows a more accurate staging. The choice of surgical strategy suffers first objective to be achieved: the radical or palliation.
Conclusion The described chest wall neoplasm is an example of how the pathologic classification is rapidly evolving thanks to new diagnostic techniques the therapeutic choices of benign primary lesions that generally occur as formations in sharp and regular margins, with a growth pattern of expansive and slow type. In the light of the latest findings in relation to the characteristics of important seat adipose tissue of adult stem cells, which are highly multidifferent, it is possible that if the cells are subjected to various types of stimuli can hypothesize and verify the activation to malignancy in time. The initiated research is that through an analysis of the lesion and on misuse formations mainly fat is it possible to get a review of the criteria in benign adipose tissue tumors.

Keywords


chest wall tumor treatment, vascular thoracic fibrous, cancer

Full Text:

References


De Alava E, Pardo J. Ewing tumor: tumor biology and clinical applications. Int J Surg Pathol. 2001;9:717.

Sandberg AA. Cytogenetics and molecular genetics of bone and soft-tissue tumors. Am J Med Genet. 2002;115:189–193.

Rosai J. Special techniques in surgical pathology. In: Rosai J. (Ed) Rosai and Ackerman’s Surgical Pathology. 9th Ed. Edinbrough, CV Mosby. 2004:37–91.

Askin FB, Rosai J, Sibley RK, Dehner LP, McAllister WH. Malignant small cell tomor of the thoracopulmonary region in childhood.A distinctive clinicopathologic entity of uncertain histogenesis.Cancer. 1979;43:2438–2451.

A Colombo et al attività cellule staminali bollettino soc medico Pavia vol 214, 2011.

Kim SY, Lee JS, Ro JY, Gay ML, Hong WK, Hittleman WN. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/ fenotype heterogeneity. Am J Pathol. 1993;142:307–317.

Vassilopoulos PP, Voros DN, Kelessis NG, Apostolikas NG. Unusual spread of liposarcoma. Anticancer Res. 2001;21: 1419–1422.

Virkus WW, Mollabashy A, Reith JD, Zlotecki RA, Berrey BH, Scarborough MT. Preoperative radiotherapy in the treatment of soft tissue sarcomas. Clin Orthop Relat Res. 2002;397:177–189.

Layfield LJ ed. Lipomatous Neoplasms. In Cytopathology of Bone and Soft Tissue Tumors. Oxford, 2002, Oxford University Press, pp 71–88.

Christopher DM, Unni KK, Mertens F. WHO classification of tumors. Pathology and genetics: tumors of soft tissue and bone. Lyon, France, 2002, IARC Press, 35–46.

Wolman SR. Fluorescence in situ hybridisation. A new tool for the pathologist. Hum Pathol. 1994;25:586–590.

Grady WW, Cheng L, Lewin KJ. Application of in situ DNA hybridization technology to diagnostic surgical pathology. Pathol Annu. 1987;22:151–175.

Houldsworth J, Chaganti RS. Comparative genomic hybridization. An overview. Am J Pathol. 1994;145:1253–1260.

Naber SP, Smith LL Jr, Wolfe HJ. Role of frozen tissue bank in molecular pathology. Diagn Mol Pathol. 1992;1:73–79.

Mies C, Houldsworth J, Chaganti RS. Extraction of DNA from paraffin blocks for Southern blot analysis. Am J Surg Pathol.1991;15:169–174.

Erlich HA, Gelfand D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science. 1991;252:1643–1651.

Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng. 2002;4:129–153.

Bertucci F, Viens P, Tagett R, Nguyen C, Houlgatte R, Birnbaum D. DNA arrays in clinical oncology: promises and challenges. Lab Invest. 2003;83:305–316.

Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors– a sub group of small-roundcell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331:294–299.

Kumar S, Pack S, Kumar D, Walker R, Quezado M, Zhuang Z, et al. Detection of EWS-FLI-1 fusion in Ewing’s sarcoma/ peripheral primitive neuroectodermal tumor by fluorescence in situ hybridization using formalin-fixed paraffin-embedded tissue. Hum Pathol. 1999;30:324–330.

Kumar S, Pelman E, Haris CA, Raffeld M, Tsokos M. Myogenin is a specific marker for rhabdomyosarcomas: an immunohistochemical study on paraffin-embedded tissues. Mod Pathol. 2001;13:988–993.

Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicatorsin alveolar rhabdomyosarcoma: a report from the chidren’s oncology group. J Clin Oncol. 2002;20:2672–2679.

Isihda M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, et al. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Mol Cell Biol. 2007;27:1348–1355.

Patricia M. McCormack, “Surgical management of chest wall tumors”, In: Arther E. Baue, Alexander S. Geha, Graeme L. Hammond, Hillel Lacks, Keith S. Naunhiem, Glenn’s Thoracic and Cardiovascular Surgery, 6th edition, Appleton and Lange.1990;593–607.

Kamal A, Mansour MD, Vinod H, Thourani MD, Albert Losken MD, Jamis G, et al. Chest wall resection and reconstruction: A 25 year experience. Ann Thorac Surg. 2002;73(1):720–726.

Graeber GM, Langenfeld J. Chest wall resection and reconstruction, In: Franco KL, Putman JR, eds. Advanced therapy in thoracic surgery. London: BC Decker, 1998;175–185.

Cavallaro A, Giorgio MPG, Cavallaro M, Graziano A. The neuroendocrine cancer personal comments and operational remarks. J Surg Surg Res. 2015;1:53–58.

Graeber GM. Chest wall resection and reconstruction. Semin Thorac Cardiovasc Surg. 1999;11(3):251–263.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.